Trial Design and Patient Population
HEART
REVIVED was a prospective, multicenter, randomized, open-label trial involving 700 patients with ILVDThe patients enrolled had a median age of 69 years, 12% were female, the median British Cardiovascular Intervention Society jeopardy score was 10, the mean baseline LVEF was 27%±6.8%, and 26% had New York Heart Association class III or IV functional status (